The survey results reveal strong enthusiasm for blood-based screening options among adults aged 45 and older, the group ...
AUSTIN, Texas--(BUSINESS WIRE)--Babson Diagnostics™, a science-first, health care technology company, today announced that a key piece of its BetterWay™ Blood Testing ecosystem has achieved 510(k) ...
Their makers claim they can detect dozens of cancer types — but some scientists say they could be missing many cancers or ...
With the approval of anti-amyloid monoclonal antibodies to treat early-stage Alzheimer’s disease (AD), the need for accurate and early diagnosis is crucial. Blood-based biomarkers offer a promising ...
Why do some people live longer than others? New research from the University of Minnesota and Duke University, recently ...
With aging populations on the rise, the need for better tools to diagnose and monitor Alzheimer's disease (AD), the most common cause of dementia, has never been more urgent. This disease is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results